{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T21:04:16Z","timestamp":1781816656565,"version":"3.54.5"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2016,3,11]],"date-time":"2016-03-11T00:00:00Z","timestamp":1457654400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100002923","name":"CONICET","doi-asserted-by":"crossref","award":["Posdoctoral fellowship"],"award-info":[{"award-number":["Posdoctoral fellowship"]}],"id":[{"id":"10.13039\/501100002923","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100002923","name":"CONICET","doi-asserted-by":"crossref","award":["Doctoral fellowship"],"award-info":[{"award-number":["Doctoral fellowship"]}],"id":[{"id":"10.13039\/501100002923","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003074","name":"ANPCyT","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003074","id-type":"DOI","asserted-by":"crossref"}]},{"name":"UBA"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Immunol Immunother"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1007\/s00262-016-1812-y","type":"journal-article","created":{"date-parts":[[2016,3,11]],"date-time":"2016-03-11T05:52:11Z","timestamp":1457675531000},"page":"551-562","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["The tumor antigen N-glycolyl-GM3 is a human CD1d ligand capable of mediating B cell and natural killer T cell interaction"],"prefix":"10.1007","volume":"65","author":[{"given":"M. Virginia","family":"Gentilini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Eugenia","family":"P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo Mariano","family":"Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo","family":"Fainboim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elo\u00edsa","family":"Arana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,3,11]]},"reference":[{"issue":"4268","key":"1812_CR1","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1126\/science.185697","volume":"194","author":"PH Fishman","year":"1976","unstructured":"Fishman PH, Brady RO (1976) Biosynthesis and function of gangliosides. Science 194(4268):906\u2013915","journal-title":"Science"},{"issue":"Suppl 2","key":"1812_CR2","first-page":"8939","volume":"107","author":"A Varki","year":"2011","unstructured":"Varki A (2011) Colloquium paper: uniquely human evolution of sialic acid genetics and biology. Proc Natl Acad Sci USA 107(Suppl 2):8939\u20138946","journal-title":"Proc Natl Acad Sci USA"},{"key":"1812_CR3","volume-title":"Essentials of glycobiology","author":"A Varki","year":"2009","unstructured":"Varki A, Kannagi R, Toole BP (2009) Glycosylation changes in cancer. In: Varki A, Cummings RD, Esko JD, Freeze HH, Stanley P, Bertozzi CR, Hart GW, Etzler ME (eds) Essentials of glycobiology, 2nd edn. Cold Spring Harbor, New York (Chapter 44)","edition":"2"},{"key":"1812_CR4","doi-asserted-by":"crossref","first-page":"814397","DOI":"10.1155\/2010\/814397","volume":"2010","author":"LE Fernandez","year":"2010","unstructured":"Fernandez LE, Gabri MR, Guthmann MD, Gomez RE, Gold S, Fainboim L, Gomez DE, Alonso DF (2010) NGcGM3 ganglioside: a privileged target for cancer vaccines. Clin Dev Immunol 2010:814397. doi: 10.1155\/2010\/814397","journal-title":"Clin Dev Immunol"},{"issue":"2","key":"1812_CR5","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/01.cji.0000188502.11348.34","volume":"29","author":"MD Guthmann","year":"2006","unstructured":"Guthmann MD, Castro MA, Cinat G, Venier C, Koliren L, Bitton RJ, Vazquez AM, Fainboim L (2006) Cellular and humoral immune response to N-Glycolyl-GM3 elicited by prolonged immunotherapy with an anti-idiotypic vaccine in high-risk and metastatic breast cancer patients. J Immunother 29(2):215\u2013223","journal-title":"J Immunother"},{"issue":"5","key":"1812_CR6","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.4049\/jimmunol.168.5.2523","volume":"168","author":"M Alfonso","year":"2002","unstructured":"Alfonso M, Diaz A, Hernandez AM, Perez A, Rodriguez E, Bitton R, Perez R, Vazquez AM (2002) An anti-idiotype vaccine elicits a specific response to N-Glycolyl sialic acid residues of glycoconjugates in melanoma patients. J Immunol 168(5):2523\u20132529","journal-title":"J Immunol"},{"key":"1812_CR7","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.4161\/cbt.6.12.5000","volume":"12","author":"S Alfonso","year":"2007","unstructured":"Alfonso S, Diaz RM, de la Torre A et al (2007) 1E10 anti-idiotype vaccine in non-small cell lung cancer: experience in stage IIIb\/IV patients. Cancer Biol Ther 12:1847\u20131852","journal-title":"Cancer Biol Ther"},{"key":"1812_CR8","doi-asserted-by":"crossref","first-page":"245181","DOI":"10.1155\/2011\/245181","volume":"2011","author":"AM Scursoni","year":"2011","unstructured":"Scursoni AM, Galluzzo L, Camarero S et al (2011) Detection of N-Glycolyl GM3 ganglioside in neuroectodermal tumors by immunohistochemistry: an attractive vaccine target for aggressive pediatric cancer. Clin Dev Immunol 2011:245181. doi: 10.1155\/2011\/245181","journal-title":"Clin Dev Immunol"},{"issue":"10","key":"1812_CR9","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1093\/glycob\/cwn072","volume":"18","author":"V Padler-Karavani","year":"2008","unstructured":"Padler-Karavani V, Yu H, Cao H, Chokhawala H, Karp F, Varki N, Chen X, Varki A (2008) Diversity in specificity, abundance, and composition of anti-Neu5Gc antibodies in normal humans: potential implications for disease. Glycobiology 18(10):818\u2013830","journal-title":"Glycobiology"},{"issue":"6151","key":"1812_CR10","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1126\/science.1241146","volume":"341","author":"D Tarlinton","year":"2013","unstructured":"Tarlinton D, Good-Jacobson K (2013) Diversity among memory B cells: origin, consequences, and utility. Science 341(6151):1205\u20131211","journal-title":"Science"},{"issue":"6585","key":"1812_CR11","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/381751a0","volume":"381","author":"K Rajewsky","year":"1996","unstructured":"Rajewsky K (1996) Clonal selection and learning in the antibody system. Nature 381(6585):751\u2013758","journal-title":"Nature"},{"issue":"8","key":"1812_CR12","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1084\/jem.20021616","volume":"197","author":"G Galli","year":"2003","unstructured":"Galli G, Nuti S, Tavarini S, Galli-Stampino L, De Lalla C, Casorati G, Dellabona P, Abrignani S (2003) CD1d-restricted help to B cells by human invariant natural killer T lymphocytes. J Exp Med 197(8):1051\u20131057","journal-title":"J Exp Med"},{"issue":"3","key":"1812_CR13","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1084\/jem.180.3.1171","volume":"180","author":"P Dellabona","year":"1994","unstructured":"Dellabona P, Padovan E, Casorati G, Brockhaus M, Lanzavecchia A (1994) An invariant V alpha 24-J alpha Q\/V beta 11 T cell receptor is expressed in all individuals by clonally expanded CD4-8- T cells. J Exp Med 180(3):1171\u20131176","journal-title":"J Exp Med"},{"issue":"3","key":"1812_CR14","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1084\/jem.180.3.1097","volume":"180","author":"O Lantz","year":"1994","unstructured":"Lantz O, Bendelac A (1994) An invariant T cell receptor alpha chain is used by a unique subset of major histocompatibility complex class I-specific CD4+ and CD4-8-T cells in mice and humans. J Exp Med 180(3):1097\u20131106","journal-title":"J Exp Med"},{"issue":"2","key":"1812_CR15","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.smim.2009.10.003","volume":"22","author":"MM Venkataswamy","year":"2009","unstructured":"Venkataswamy MM, Porcelli SA (2009) Lipid and glycolipid antigens of CD1d-restricted natural killer T cells. Semin Immunol 22(2):68\u201378","journal-title":"Semin Immunol"},{"issue":"2","key":"1812_CR16","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/ni.2511","volume":"14","author":"CG Vinuesa","year":"2013","unstructured":"Vinuesa CG, Chang PP (2013) Innate B cell helpers reveal novel types of antibody responses. Nat Immunol 14(2):119\u2013126","journal-title":"Nat Immunol"},{"issue":"5","key":"1812_CR17","doi-asserted-by":"crossref","first-page":"e5325","DOI":"10.1371\/journal.pone.0005325","volume":"4","author":"D Cox","year":"2009","unstructured":"Cox D, Fox L, Tian R, Bardet W, Skaley M, Mojsilovic D, Gumperz J, Hildebrand W (2009) Determination of cellular lipids bound to human CD1d molecules. PLoS ONE 4(5):e5325. doi: 10.1371\/journal.pone.0005325","journal-title":"PLoS ONE"},{"issue":"6","key":"1812_CR18","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.4049\/jimmunol.148.6.1941","volume":"148","author":"J Zemmour","year":"1992","unstructured":"Zemmour J, Little AM, Schendel DJ, Parham P (1992) The HLA-A, B \u201cnegative\u201d mutant cell line C1R expresses a novel HLA-B35 allele, which also has a point mutation in the translation initiation codon. J Immunol 148(6):1941\u20131948","journal-title":"J Immunol"},{"issue":"1","key":"1812_CR19","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1084\/jem.186.1.109","volume":"186","author":"M Exley","year":"1997","unstructured":"Exley M, Garcia J, Balk SP, Porcelli S (1997) Requirements for CD1d recognition by human invariant Valpha24+ CD4-CD8-T cells. J Exp Med 186(1):109\u2013120","journal-title":"J Exp Med"},{"key":"1812_CR20","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jim.2009.04.002","volume":"345","author":"T Shiratsuchi","year":"2009","unstructured":"Shiratsuchi T, Schneck J, Kawamura A, Tsuji M (2009) Human CD1 dimeric proteins as indispensable tools for research on CD1-binding lipids and CD1-restricted T cells. J Immunol Methods 345:49\u201359","journal-title":"J Immunol Methods"},{"key":"1812_CR21","doi-asserted-by":"crossref","first-page":"3744","DOI":"10.1158\/0008-5472.CAN-11-2695","volume":"72","author":"TJ Webb","year":"2012","unstructured":"Webb TJ, Li X, Giuntoli RL, Lopez PH, Heuser C, Schnaar RL, Tsuji M, Kurts C, Oelke M, Schneck JP (2012) Molecular identification of GD3 as a suppressor of the innate immune response in ovarian cancer. Cancer Res 72:3744\u20133752","journal-title":"Cancer Res"},{"key":"1812_CR22","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.4049\/jimmunol.0901208","volume":"184","author":"V Lombardi","year":"2010","unstructured":"Lombardi V, Stock P, Singh AK, Kerzerho J, Yang W, Sullivan BA, Li X, Shiratsuchi T, Hnatiuk NE, Howell AR, Yu KO, Porcelli SA, Tsuji M, Kronenberg M, Wilson SB, Akbari O (2010) A CD1d-dependent antagonist inhibits the activation of invariant NKT and prevents development of allergen-induced airway hyperreactivity. J Immunol 184:2107\u20132115","journal-title":"J Immunol"},{"key":"1812_CR23","doi-asserted-by":"crossref","first-page":"6019","DOI":"10.1021\/ac000846l","volume":"72","author":"AK Singh","year":"2000","unstructured":"Singh AK, Harrison SH, Schoeniger JS (2000) Gangliosides as receptors for biological toxins: development of sensitive fluoroimmunoassays using ganglioside-bearing liposomes. Anal Chem 72:6019\u20136024","journal-title":"Anal Chem"},{"issue":"10","key":"1812_CR24","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1038\/icb.2014.59","volume":"92","author":"ME Perez","year":"2014","unstructured":"Perez ME, Billordo LA, Baz P, Fainboim L, Arana E (2014) Human memory B cells isolated from blood and tonsils are functionally distinctive. Immunol Cell Biol 92(10):882\u2013887","journal-title":"Immunol Cell Biol"},{"issue":"7","key":"1812_CR25","doi-asserted-by":"crossref","first-page":"4046","DOI":"10.4049\/jimmunol.167.7.4046","volume":"167","author":"SM Tahir","year":"2001","unstructured":"Tahir SM, Cheng O, Shaulov A, Koezuka Y, Bubley GJ, Wilson SB, Balk SP, Exley MA (2001) Loss of IFN-\u03b3 production by invariant NK T cells in advanced cancer. J Immunol 167(7):4046\u20134050","journal-title":"J Immunol"},{"issue":"5","key":"1812_CR26","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1084\/jem.188.5.867","volume":"188","author":"M Exley","year":"1998","unstructured":"Exley M, Porcelli S, Furman M, Garcia J, Balk S (1998) CD161 (NKR-P1A) costimulation of CD1d-dependent activation of human T cells expressing invariant V alpha 24\u00a0J alpha Q T cell receptor alpha chains. J Exp Med 188(5):867\u2013876","journal-title":"J Exp Med"},{"issue":"1","key":"1812_CR27","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/0022-1759(86)90384-4","volume":"90","author":"R Schwarting","year":"1986","unstructured":"Schwarting R, Gerdes J, Niehus J, Jaeschke L, Stein H (1986) Determination of the growth fraction in cell suspensions by flow cytometry using the monoclonal antibody Ki-67. J Immunol Methods 90(1):65\u201370","journal-title":"J Immunol Methods"},{"key":"1812_CR28","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1146\/annurev.immunol.15.1.535","volume":"15","author":"A Bendelac","year":"1997","unstructured":"Bendelac A, Rivera MN, Park SH, Roark JH (1997) Mouse CD1-specific NK1 T cells: development, specificity, and function. Annu Rev Immunol 15:535\u2013562","journal-title":"Annu Rev Immunol"},{"key":"1812_CR29","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1600-065X.1999.tb01304.x","volume":"169","author":"S Hong","year":"1999","unstructured":"Hong S, Scherer DC, Singh N, Mendiratta SK, Serizawa I, Koezuka Y, Van Kaer L (1999) Lipid antigen presentation in the immune system: lessons learned from CD1d knockout mice. Immunol Rev 169:31\u201344","journal-title":"Immunol Rev"},{"issue":"5","key":"1812_CR30","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.4049\/jimmunol.163.5.2373","volume":"163","author":"N Singh","year":"1999","unstructured":"Singh N, Hong S, Scherer DC, Serizawa I, Burdin N, Kronenberg M, Koezuka Y, Van Kaer L (1999) Cutting edge: activation of NK T cells by CD1d and alpha-galactosylceramide directs conventional T cells to the acquisition of a Th2 phenotype. J Immunol 163(5):2373\u20132377","journal-title":"J Immunol"},{"issue":"9","key":"1812_CR31","doi-asserted-by":"crossref","first-page":"3352","DOI":"10.1158\/0008-5472.CAN-10-4102","volume":"71","author":"V Padler-Karavani","year":"2011","unstructured":"Padler-Karavani V, Hurtado-Ziola N, Pu M et al (2011) Human xeno-autoantibodies against a non-human sialic acid serve as novel serum biomarkers and immunotherapeutics in cancer. Cancer Res 71(9):3352\u20133363","journal-title":"Cancer Res"},{"issue":"43","key":"1812_CR32","doi-asserted-by":"crossref","first-page":"37692","DOI":"10.1074\/jbc.M111.267948","volume":"286","author":"NA Haig","year":"2011","unstructured":"Haig NA, Guan Z, Li D, McMichael A, Raetz CR, Xu XN (2011) Identification of self-lipids presented by CD1c and CD1d proteins. J Biol Chem 286(43):37692\u201337701","journal-title":"J Biol Chem"},{"key":"1812_CR33","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1038\/ni.2143","volume":"12","author":"PJ Brennan","year":"2011","unstructured":"Brennan PJ, Tatituri RV, Brigl M, Kim EY, Tuli A, Sanderson JP, Gadola SD, Hsu FF, Besra GS, Brenner MB (2011) Invariant natural killer T cells recognize lipid self-antigen induced by microbial danger signals. Nat Immunol 12:1202\u20131211","journal-title":"Nat Immunol"},{"issue":"4","key":"1812_CR34","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.immuni.2014.08.017","volume":"41","author":"L Kain","year":"2014","unstructured":"Kain L, Webb B, AndersonL BL, Deng S, Costanzo A, Holt M, Self K, Zhao M, Teyton A, Kronenberg M, Everett C, Bendelac A, Zajonc DM, Savage PB, Teyton L (2014) The identification of the endogenous ligands of natural killer T cells reveals the presence of mammalian alpha-linked glycosylceramides. Immunity 41(4):543\u2013554","journal-title":"Immunity"},{"key":"1812_CR35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0378-4347(98)00122-4","volume":"710","author":"D Heitmann","year":"1998","unstructured":"Heitmann D, Ziehr H, Muthing J (1998) Large scale purification of gangliosides GM3(Neu5Ac) and GM3(Neu5Gc) by trimethylaminoethyl-Fractogel high-performance liquid chromatography. J Chromatogr B Biomed Sci Appl 710:1\u20138","journal-title":"J Chromatogr B Biomed Sci Appl"},{"issue":"7","key":"1812_CR36","doi-asserted-by":"crossref","first-page":"3052","DOI":"10.1073\/pnas.0915056107","volume":"107","author":"K Muindi","year":"2010","unstructured":"Muindi K, Cernadas M, Watts GF et al (2010) Activation state and intracellular trafficking contribute to the repertoire of endogenous glycosphingolipids presented by CD1d [corrected]. Proc Natl Acad Sci 107(7):3052\u20133057","journal-title":"Proc Natl Acad Sci"},{"issue":"1","key":"1812_CR37","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/j.1365-2567.2007.02760.x","volume":"123","author":"JE Park","year":"2008","unstructured":"Park JE, Wu DY, Prendes M, Lu SX, Ragupathi G, Schrantz N, Chapman PB (2008) Fine specificity of natural killer T cells against GD3 ganglioside and identification of GM3 as an inhibitory natural killer T-cell ligand. Immunology 123(1):145\u2013155","journal-title":"Immunology"},{"issue":"8","key":"1812_CR38","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1007\/s00262-002-0298-y","volume":"51","author":"AD Gritzapis","year":"2002","unstructured":"Gritzapis AD, Dimitroulopoulos D, Paraskevas E, Baxevanis CN, Papamichail M (2002) Large-scale expansion of CD3(+)CD56(+) lymphocytes capable of lysing autologous tumor cells with cytokine-rich supernatants. Cancer Immunol Immunother 51(8):440\u2013448","journal-title":"Cancer Immunol Immunother"},{"issue":"2","key":"1812_CR39","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1182\/blood-2004-04-1537","volume":"105","author":"M Giroux","year":"2005","unstructured":"Giroux M, Denis F (2005) CD1d-unrestricted human NKT release chemokines upon Fas engagement. Blood 105(2):703\u2013710","journal-title":"Blood"}],"container-title":["Cancer Immunology, Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-016-1812-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00262-016-1812-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-016-1812-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,17]],"date-time":"2023-08-17T05:53:13Z","timestamp":1692251593000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00262-016-1812-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,11]]},"references-count":39,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,5]]}},"alternative-id":["1812"],"URL":"https:\/\/doi.org\/10.1007\/s00262-016-1812-y","relation":{},"ISSN":["0340-7004","1432-0851"],"issn-type":[{"value":"0340-7004","type":"print"},{"value":"1432-0851","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,11]]}}}